These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 34435935)

  • 41. The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine.
    Farid E; Herrera-Uribe J; Stevenson NJ
    Front Immunol; 2022; 13():817597. PubMed ID: 35711448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.
    Powell J; Piszczatoski CR
    Ann Pharmacother; 2022 Sep; 56(9):1058-1064. PubMed ID: 35012364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.
    Ciccarese G; Parodi A; Drago F
    Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411
    [No Abstract]   [Full Text] [Related]  

  • 46. Pityriasis Rosea in Kaduna, North-West Nigeria: A 20-Year Experience.
    Yahya H
    West Afr J Med; 2023 Jul; 40(7):704-710. PubMed ID: 37515778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.
    Akdaş E; İlter N; Öğüt B; Erdem Ö
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e491-e493. PubMed ID: 33914958
    [No Abstract]   [Full Text] [Related]  

  • 48. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.
    Mehta H; Handa S; Malhotra P; Patial M; Gupta S; Mukherjee A; Chatterjee D; Takkar A; Mahajan R
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e16-e18. PubMed ID: 34547126
    [No Abstract]   [Full Text] [Related]  

  • 49. Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.
    Busto-Leis JM; Servera-Negre G; Mayor-Ibarguren A; Sendagorta-Cudós E; Feito-Rodríguez M; Nuño-González A; Montero-Vega MD; Herranz-Pinto P
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e489-e491. PubMed ID: 33899974
    [No Abstract]   [Full Text] [Related]  

  • 50. Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report.
    Lemoine C; Padilla C; Krampe N; Doerfler S; Morgenlander A; Thiel B; Aggarwal R
    Clin Rheumatol; 2022 May; 41(5):1597-1601. PubMed ID: 35294664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
    Dursun R; Temiz SA
    Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pityriasis Rosea: Diagnosis and Treatment.
    Villalon-Gomez JM
    Am Fam Physician; 2018 Jan; 97(1):38-44. PubMed ID: 29365241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A clinicoepidemiological study of pityriasis rosea in South India.
    Ganguly S
    Skinmed; 2013; 11(3):141-6. PubMed ID: 23930352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study.
    Yüksel M
    Acta Derm Venereol; 2019 Jun; 99(7):664-667. PubMed ID: 30848285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination.
    Algaissi A; Alamer E; Jeraiby M; Alomaish A; Elrhima O; Qumayi S; Qasir NA; Areeshi H; Masmali A; Alhazmi A
    Saudi Med J; 2022 Jun; 43(6):567-571. PubMed ID: 35675927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pityriasis rosea developing after COVID-19 vaccination.
    Marcantonio-Santa Cruz OY; Vidal-Navarro A; Pesqué D; Giménez-Arnau AM; Pujol RM; Martin-Ezquerra G
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e721-e722. PubMed ID: 34237178
    [No Abstract]   [Full Text] [Related]  

  • 57. A case of hemichorea following administration of the Pfizer-BioNTech COVID-19 vaccine.
    Ryu DW; Lim EY; Cho AH
    Neurol Sci; 2022 Feb; 43(2):771-773. PubMed ID: 34811599
    [No Abstract]   [Full Text] [Related]  

  • 58. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.
    Drago F; Ciccarese G; Javor S; Parodi A
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):544-5. PubMed ID: 25545307
    [No Abstract]   [Full Text] [Related]  

  • 60. Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination.
    Leerunyakul K; Pakornphadungsit K; Suchonwanit P
    Front Med (Lausanne); 2021; 8():752443. PubMed ID: 34557507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.